The Conafay Group works with life science companies and organizations to develop and implement government funding and public policy strategies. We also bridge ties to philanthropic, non-profit, academic and commercial entities to enhance client outcomes. We create and execute dynamic strategies on behalf of our clients which facilitate the following: - Non-Dilutive Funding - Health Policy Advocacy - Ally Development - Public-Private Partnerships - Federal Marketing - Coalition Management - Business-to-Business PartneringWe specialize in representing biomedical technologies and therapeutics to the federal government and associated stakeholders.

The Conafay Group works with life science companies and organizations to develop and implement government funding and public policy strategies. We also bridge ties to philanthropic, non-profit, academic and commercial entities to enhance client outcomes. We create and execute dynamic strategies on behalf of our clients which facilitate the following: - Non-Dilutive Funding - Health Policy Advocacy - Ally Development - Public-Private Partnerships - Federal Marketing - Coalition Management - Business-to-Business PartneringWe specialize in representing biomedical technologies and therapeutics to the federal government and associated stakeholders.

Contractor supporting the regenerative medicine portfolio of the Clinical and Rehabilitative Medicine Research Program within the Army Medical Research and Materiel Comand located at Fort Deterick. Primary activities include managing and providing strategic guidance to approximately $60 million dollars in annual regenerative medicine expenditures for programs throughout the Department of Defense including the Armed Forces Institute of Regenerative Medicine (www.afirm.mil).

A private regenerative medicine company developing cell-based and tissue modifying technologies to address damaged and diseased articular cartilage and intervertebral disc tissues.

A contract lab specializing in food quality, safety and sensory analysis.

A private regenerative medicine company developing cell-based and tissue modifying technologies to address damaged and diseased articular cartilage and intervertebral disc tissues.